Dr. Lu Wang is Chief of the Translational Genomics Research Branch and Director of the Translational Genetics and Genomics Program. She manages a funding portfolio covering the areas of genetics, genetic epidemiology, functional genomics, genomics methods, bioinformatics, data repository, genetic disease diagnosis, and bioethics aimed at improving dental, oral, and craniofacial health. Dr. Wang chairs NIDCR’s Data Access Committees that manage public access to the genomic and phenotypic data produced by NIDCR-funded researchers. Prior to joining NIDCR, Dr. Wang was Program Director at the National Human Genome Research Institute (NHGRI) overseeing genomics, disease genetics, genome editing, and SBIR/STTR programs.
Prior to joining NIH, Dr. Wang served as VP of Research and Development and Chief Operations Officer in the private sector and led development and commercialization of a number of FDA 510(k)-cleared molecular products serving transplant diagnostics and immunogenetics research. Dr. Wang has been a leading or co-author of publications about NIH-led scientific initiatives, genomics methods, or mechanisms of transcriptional regulation. She holds B.S. and M.S. degrees in genetics. She earned her Ph.D. in microbiology from Cornell University while studying nutrient-modulated transcriptional regulation. She received her postdoctoral training at The Rockefeller University while studying the transcriptional regulation of B-lymphocyte development.